Merit Medical SystemsMMSI
About: Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Employees: 6,950
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
12,410% more call options, than puts
Call options by funds: $89.1M | Put options by funds: $712K
141% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 34
15% more funds holding
Funds holding: 318 [Q2] → 366 (+48) [Q3]
11% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 113
9% more capital invested
Capital invested by funds: $5.31B [Q2] → $5.81B (+$495M) [Q3]
5.03% less ownership
Funds ownership: 106.35% [Q2] → 101.32% (-5.03%) [Q3]
67% less funds holding in top 10
Funds holding in top 10: 3 [Q2] → 1 (-2) [Q3]
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
Needham Mike Matson 74% 1-year accuracy 84 / 114 met price target | 7%upside $109 | Buy Reiterated | 31 Oct 2024 |
Barrington Research Michael Petusky 51% 1-year accuracy 33 / 65 met price target | 12%upside $114 | Outperform Maintained | 31 Oct 2024 |
Baird David Rescott 81% 1-year accuracy 13 / 16 met price target | 7%upside $109 | Outperform Maintained | 31 Oct 2024 |
Barrington Research Michael Petusky 51% 1-year accuracy 33 / 65 met price target | 12%upside $114 | Outperform Maintained | 18 Oct 2024 |
Barrington Research Michael Petusky 51% 1-year accuracy 33 / 65 met price target | 12%upside $114 | Outperform Maintained | 20 Sept 2024 |
Financial journalist opinion
Based on 11 articles about MMSI published over the past 30 days
